Low LDL levels per se are not simply associated with decreased sepsis survival, because lowering LDL levels by inhibiting LDL production (statin treatment) is associated with adverse outcomes, while increased LDL clearance (PCSK9 loss-of-function genotype) is associated with improved outcomes in patients with low VAT/SAT. The gene discussed is PCSK9; the disease is Sepsis.